Severe ARDS Secondary to Pneumonia Requiring VV ECMO in the Setting of Newly Diagnosed Hairy Cell Leukemia
Venovenous (VV) extracorporeal membrane oxygenation (ECMO) for severe acute respiratory distress syndrome (ARDS) is initiated in patients with high mortality as a potential lifesaving intervention. Hematologic malignancy (HM) is considered a relative exclusion criterion by the Extracorporeal Life Su...
Saved in:
Main Authors: | Daniel Gorman DO, MS (Author), Adam Green MD (Author), Nitin Puri MD (Author), Phil Dellinger MD, MCCM (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cryotherapy: A Safe Approach to Pulmonary Hemorrhage During VV-ECMO
by: Adam Green MD, et al.
Published: (2022) -
Successful Application of Argatroban During VV-ECMO in a Pregnant Patient Complicated With ARDS due to Severe Tuberculosis: A Case Report and Literature Review
by: Hongxia Wu, et al.
Published: (2022) -
Concomitantly Diagnosed Disseminated Infection and Hairy Cell Leukemia With Review of Pathophysiology
by: Daniel J. Stanton MD, et al.
Published: (2024) -
Venovenous extracorporeal membrane oxygenation (VV ECMO) in community-acquired pneumonia caused by Klebsiella pneumoniae. What went wrong?
by: Krystian Adrian Ślusarz, et al.
Published: (2019) -
Venovenous extracorporeal membrane oxygenation (VV ECMO) in community-acquired pneumonia caused by Klebsiella pneumoniae. What went wrong?
by: Krystian Adrian Ślusarz, et al.
Published: (2019)